Novartis

theatre stage with red curtains
Biotech

Novartis’ phase 3 wins in Sjögren's see high placebo effect

Novartis is pulling back the curtain on late-stage Sjögren's wins, revealing an edge over placebo in both studies.
Gabrielle Masson Oct 29, 2025 12:03pm
NVS

Novartis pays $12B for late-stage dystrophy biotech Avidity

Oct 26, 2025 4:01pm
Stethoscope and red heart with pink background

US VC launches another biotech with China-licensed asset

Sep 17, 2025 10:30am
closed shuttered shut down closed

Sanofi becomes latest pharma to hold fire on UK R&D investments

Sep 15, 2025 10:14am
glue scissors art supplies

Novartis pens Monte Rosa molecular glue pact worth up to $5.7B

Sep 15, 2025 9:07am
A chessboard with blocks that read MA

Novartis spends $1.4B for Tourmaline, CV med that wowed in ph. 2

Sep 9, 2025 4:28am